Bio-Path at-a-Glance ; NASDAQ: BPTH ; Focus: Drug delivery for nucleic acid drugs ; Shares Outstanding: 617,633 ; Cash (at 12/31/23):, $1.1 million ; Burn rate: $1.0 ...
Investors · Overview · SEC Filings · Corporate Governance · Media · Press Releases · Events · Presentations & Publications · Careers · Contact Us. A new path in ...
Get the latest insights on Bio-Path Holdings, Inc. Common Stock (BPTH) with press releases and corporate news to help you in your trading and investing ...
Bio-Path Holdings, Inc. Common Stock (BPTH) SEC Filings - Nasdaq
www.nasdaq.com › ... › Stocks › BPTH
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Secretary, Director & Director-Investor Relations; Aline Sherwood Independent Director; Heath W Cleaver CPA Independent Director; Paul D Aubert MBA Independent ...
Get Bio Path Holdings Inc (BPTH.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.
Find the latest Bio-Path Holdings, Inc. (BPTH) stock quote, history, news and other vital information to help you with your stock trading and investing.
Missing: relations | Show results with:relations
Bio-Path Holdings (BPTH) Earnings Dates & Reports - TipRanks.com
www.tipranks.com › stocks › earnings
Rating
(975)
Bio-Path Holdings (BPTH) will release its next earnings report on May 15, 2024 ... investors and does not represent returns that any investor actually attained.
(NasdaqCM:BPTH) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size.
View today's Bio Path Holdings Inc stock price and latest BPTH news and analysis. Create real-time notifications to follow any changes in the live stock ...
Missing: relations | Show results with:relations